(1)
YuX.; LiuJ.; QiuH.; HaoH.; ZhuJ.; PengS. Combined Inhibition of ACK1 and AKT Shows Potential Toward Targeted Therapy Against KRAS-Mutant Non-Small-Cell Lung Cancer. Bosn J of Basic Med Sci 2020.